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1 Introduction 
Cardiovascular diseases (CVD) are the main causes of 
death in the Western world. High concentrations of low-density 
lipoprotein (LDL) and high density lipoprotein (HDL) are major 
risk factors for the development of these diseases (NCEP, 2001). 
High levels of triglycerides or lipoprotein of very low density 
(VLDL) also represent risk factors, and the extent of this risk 
depends on low HDL-C and other interrelated risk factors, such 
as smoking, visceral obesity, hypertension, and insulin resistance 
(KRAUSS et al., 2000; NCEP, 2001). 
Cardiovascular diseases are caused by atherosclerosis, 
a process characterized by the endothelial dysfunction and 
deposit of cholesterol into macrophages and smooth muscle 
cells in the endothelial wall due to high levels of LDL-C, 
lipoprotein (a), remnant lipoprotein, and low levels of HDL-C 
(SCHAEFER, 2002). Hypercholesterolemia is critical to the 
formation of atherosclerosis. The presence of heart disease in 
populations with average total cholesterol less than 180 mg.dL-1 
(SCHAEFER, 2002) is unusual.
Resumo
As doenças cardiovasculares (DCV) são a principal causa de morte no mundo ocidental. Entre os fatores de risco modificáveis pela dieta para 
reduzir os riscos de doenças cardiovasculares destacam-se as concentrações plasmáticas de colesterol total, triglicérides, LDL-C e HDL-C. 
Medidas dietéticas podem ser adotadas para equilibrar estes componentes do perfil lipídico e, assim, prevenir doenças cardiovasculares. 
Os principais componentes dos alimentos que afetam o perfil lipídico e cuja ingestão pode ser modificada pela dieta são as gorduras 
saturadas e gorduras trans, gorduras insaturadas, colesterol, fitosteróis, proteínas vegetais e fibras solúveis. Há uma riqueza de evidências 
de que gorduras saturadas e trans e colesterol da dieta aumentam as concentrações do colesterol plasmático total e do LDL-C. As gorduras 
trans também reduzem o HDL-C, uma lipoproteína importante para mediar o transporte reverso do colesterol. Por outro lado, fitosteróis, 
proteínas vegetais, isoflavonas e fibras solúveis são fatores da dieta protetores na doença cardiovascular, modulando os níveis plasmáticos de 
lipoproteína. Estes componentes dos alimentos em determinadas concentrações são capazes de reduzir o colesterol total, TG e LDL-C e elevar 
os níveis plasmáticos de HDL-C. A dieta é, portanto, uma importante ferramenta para a prevenção e controle das doenças cardiovasculares, 
sendo importante considerá-la como um todo, não apenas os componentes dos alimentos que modulam as concentrações plasmáticas de 
lipoproteínas, mas também o conteúdo da dieta de macronutrientes e micronutrientes.
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Abstract
Cardiovascular diseases (CVD) are the main causes of death in the Western world. Among the risk factors that are modifiable by diet, 
for reducing cardiovascular disease risks, the total plasma concentrations of cholesterol, triglycerides, LDL-C, and HDL-C are the most 
important. Dietary measures can balance these components of the lipid profile thus reducing the risk of cardiovascular diseases. The main 
food components that affect the lipid profile and can be modified by diet are the saturated and trans fats, unsaturated fats, cholesterol, 
phytosterols, plant protein, and soluble fiber. A wealth of evidence suggests that saturated and trans fats and cholesterol in the diet raise the 
total plasma cholesterol and LDL-C. Trans fats also reduce HDL-C, an important lipoprotein for mediating the reverse cholesterol transport. 
On the other hand, phytosterols, plant proteins, isoflavones, and soluble fiber are protective diet factors against cardiovascular diseases by 
modulating plasma lipoprotein levels. These food components at certain concentrations are able to reduce the total cholesterol, TG, and 
LDL-C and raise the plasma levels of HDL-C. Therefore, diet is an important tool for the prevention and control of cardiovascular diseases, 
and should be taken into account as a whole, i.e., not only the food components that modulate plasma concentrations of lipoproteins, but 
also the diet content of macro nutrients and micronutrients should be considered.
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Unsaturated fatty acids
(ALA) is found in green tissues of plants, soybean oil, flaxseed, 
and canola. The n-6 fatty acids are found in vegetable oils, except 
for coconut, cocoa, and palm oil. The main sources of oleic acid 
are olive, canola, avocado, and oilseeds (peanuts, chestnuts, 
walnuts, almonds) (SPOSITO et al., 2007). 
The degree of saturation of dietary lipids plays an important 
role in modulating plasma cholesterol concentration, which 
determines the risk of cardiovascular diseases (FERNANDEZ; 
WEST, 2005). The isocaloric replacement of saturated fatty acids 
by PUFA reduces the plasma concentrations of total cholesterol 
and LDL-C. The PUFA have the disadvantage of inducing 
increased lipid oxidation and decreasing HDL-C when used 
in large quantities. The n-3 fatty acids (ALA, EPA, and DHA) 
promote the reduction of plasma triglycerides by decreasing 
hepatic synthesis of VLDL. Monounsaturated fatty acids (oleic 
acid) have the same effect on cholesterol without, however, 
reducing HDL-C and causing lipid oxidation (SPOSITO et al., 
2007).
Several studies have shown that the consumption of EPA 
and DHA is inversely related to the incidence of cardiovascular 
diseases. However, this is not observed for the ALA because 
the ALA from plant sources is converted to EPA at very low 
rates, less than 5%, and the conversion to DHA is even lower, 
0.5% (WANG et al., 2006; PLOURDE; CUNNANE, 2007). 
Goyens et al (2005) observed that this inefficient conversion of 
ALA into EPA is probably related to limited incorporation of 
ALA in the pool of liver phospholipids. The presence of linoleic 
acid (LA, n = 6) also affects this conversion. The ALA and LA 
compete for the δ-6/5-dessaturase enzyme in the process of 
desaturation and elongation. Thus, the incorporation of ALA 
into plasma and tissue lipids and its conversion into long chain 
fatty acids of the n-3 fatty acids (EPA and DHA) are influenced 
by the levels of LA (HU, 2001b) 
The triglyceride-lowering effect by the EPA and DHA has 
been detailed in several studies. The dose-response relationship 
between EPA and DHA and the reduction of triglycerides is 
believed to be in the range from 2 to 4 g/day for reducing plasma 
triglycerides by 20 to 50% (KRIS-ETHERTON; HARRIS, 2002). 
Although the mechanism of triglyceride reduction by n-3 fatty 
acids is not completely understood, it is believed that it may 
be due to the lower hepatic synthesis, which is related to the 
inhibition of acyl-CoA: 1,2-diacylglycerol O-acyltransferase 
and/or the induction the peroxisome beta-oxidation in the liver 
(RUSTAN et al., 1988; JUMP, 2004). 
Evidence of the cardioprotective effect of n-3 fatty acids was 
observed in 2 studies of intervention in secondary prevention 
(Diet and Reinfarction Trial – DART and Gruppo Italiano per lo 
Studio della Sopravvivenza nell’Infarto miocardico – GISSI). The 
DART study demonstrated a 29% reduction in total mortality 
at 2 years in patients recovered from myocardial infarction, 
advised to consume fat fish 2 times a week (BURR et al., 1989). 
After two years of study, it was observed that consumption 
of EPA increased by four times (2.4 g/week) compared to the 
intake of 0.6 g/week in the control group (BURR et al., 1989). 
The GISSI prevention study was designed to investigate the 
effect of fish oil on morbidity and mortality after a heart attack. 
Patients supplemented with 1 g/day fish oil (850 to 882 mg of 
According to the report of strategies for reducing blood 
cholesterol, the National Cholesterol Education Program 
(2001) estimated that a 1% reduction in serum cholesterol 
reduces the risk of cardiovascular disease in 2 to 3%. This 
document recognizes that the dietary therapy is an important 
tool to reduce and control cholesterol levels. Diet can promote a 
gradual decrease in LDL cholesterol of about 10 to 13%. A small 
reduction, estimated in 1.8 mg.dL-1, in LDL-C reduces the risk 
of cardiovascular events (heart attack, stroke, hospitalization for 
unstable angina, or revascularization) in 1% (CANNON et al., 
2006).
The purpose of this review is to present objectively the main 
food components that are involved in the modulation of blood 
cholesterol and lipoproteins and the consequent prevention or 
control of cardiovascular disease by dietary means.
2 Dietary Components 
2.1 Dietary lipids
Fatty acids
Fatty acids are saponifiable organic substances, which can be 
classified as saturated or unsaturated depending on the absence 
or presence of double bond in the carbon chain, respectively. 
Unsaturated fatty acids are classified as monounsaturated or 
polyunsaturated depending on the number of unsaturations in 
the molecule. Most fats contain different proportions of each of 
these fatty acids, but they are usually classified according to the 
predominant type. Unsaturated fatty acids are predominantly 
of plant origin, whose oils are extracted from cereals, legumes, 
and fruits while the saturated fatty acids are predominantly 
of animal origin. However, coconut, cocoa, and palm oils are 
predominantly constituted of saturated fatty acids, whereas fish 
oil is rich in unsaturated fatty acids.
The concentration of plasma lipoproteins is modified by 
both the quantity and the quality of lipid consumed (saturated 
fatty acids, monounsaturated, polyunsaturated, and trans) and 
the balance of these fatty acids that is more relevant than the 
total amount of dietary fat (KASIM-KARAKAS et al., 2000; 
HU et al., 2001a). 
Unsaturated fatty acids 
Unsaturated fatty acids are represented by n-3 families: 
α-linolenic acid (ALA 18:3 n-3), eicosapentaenoic acid (EPA 20:5 
n-3), and docosahexaenoic acid (DHA 22:6 n-3); n-6 families: 
linoleic acid (LA 18:2 n-6) and arachidonic acid (20:4 n-6); 
and n-9 families: oleic acid (cis18: 1n-9). Polyunsaturated fatty 
acids (PUFA), precursors of n-3 and n-6 families, linoleic, and 
linolenic acid, respectively, are defined as essential fatty acids 
because they are not synthesized endogenously by humans 
due to lack of desaturase enzymes, which are capable of 
inserting double bonds between carbon 3-4 and 6-7, as well as 
hydrogenase enzymes capable of removing such unsaturation. 
The main sources of EPA and DHA are cold-water fish such 
as mackerel, sardines, herring, and salmon. Alfa linoleic acid 
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alternative to reduce total cholesterol and LDL-C (van 
HORN et al., 2008). 
Trans fatty acids
The main sources of trans fatty acids (TFA) are partially 
hydrogenated fats and products made with these fats, such as 
bakery products and fried foods. A small proportion of trans 
fatty acids (TFA) of the diet originates from fat of ruminant 
animals found mainly in meat and whole milk; vaccenic acid 
(trans 18:1 n-7) and elaidic acid (trans 18:1 n-9) represent 
most of the TFAS originated from the partial hydrogenation 
of vegetable oils. 
The consumption of trans fatty acids adversely affects 
plasma lipids and lipoproteins, increasing LDL-C and lowering 
HDL-C. The TFA consumption increases the levels of fasting 
triglycerides as in comparison to the same amounts of MUFA 
and PUFA consumption (MOZAFFARIAN; CLARKE, 2009). 
In an observational study, it was found that the consumption 
of 2.6 to 3.6 g/day of TFA was associated with higher levels of 
LDL-C, lower levels of HDL-C, and higher LDL-C/HDL-C ratios 
(SUN et al., 2007). The mechanisms by which TFA promote these 
changes seems to be due to the increased activity of the protein 
carrier of cholesteryl esters (CETP), which may contribute to 
the increase in the production of LDL-C and low production of 
HDL-C when the TFA is consumed (van TOL et al., 1995).
Ascherio et al. (1999) reviewed some studies that evaluated 
the effect of consumption of TFA on plasma levels of LDL and 
HDL and suggested that 2% increase in the intake of trans 
fatty acids may be responsible to an increase of 0.1 in the 
LDL-C/HDL-C ratio. It has been observed that the increase 
of one unit (1.0) in this relationship is associated with an 
elevation in about 53% of the risk of cardiovascular disease 
(STAMPFER et al., 1991). Trans isomers may also interfere 
with the biological functions of LA and ALA, which compete 
for the δ-6/5-desaturase enzyme. This enzyme is responsible for 
the desaturation of ALA in the process of converting the same 
into EPA and DHA (KINSELLA et al., 1981).
According to the IV Brazilian Guidelines on Dyslipidemia 
and Prevention of Atherosclerosis, there is no consensus on the 
maximum allowed amount of trans fat in the diet. However, it is 
recommended that the intake of this fat should be less than 1% 
of total calories (SPOSITO et al., 2007). The recommendation 
of ANVISA (2003) is that the consumption of TFAs should not 
exceed 2 g/day for adults. The Brazilian Society of Cardiology, 
under the guidelines of the American Heart Association, 
recommends that the consumption of total fat is between 
25 to 35% of the total energy of the diet. The consumption 
of SFA should be <7%, polyunsaturated fatty acids <10%, 
monounsaturated fatty acids, and <20% of the total energy of 
the diet (SPOSITO et al., 2007).
Dietary sterols 
Sterols are unsaponifiable lipids containing a perhi-
dropenteno-phenanthrene core. Sterols can be of animal or 
vegetable origin, being cholesterol and phytosterol their major 
components, respectively (Figure 1).
EPA + DHA) had a 20% reduction in risk of total mortality and 
30% reduction in risk of death from cardiovascular disease, 
and 47% reduction in risk of sudden death (GISSI, 1999; 
MARCHIOLI et al., 2002). These cardioprotective benefits 
have been largely attributed to the anti-arrhythmic effect of 
EPA and DHA, but are also related to the improvement of other 
cardiovascular risk factors.
Based on evidences, the Food and Drug Administration 
(FDA) approved in November 2004 the administration 
of omega-3 fatty acids to reduce triglyceride levels in 
hypertriglyceridemic adults (> 500 mg.dL-1) as an adjunct 
to diet (FDA, 2004). The American Heart Association 
recommends, for the general population, the consumption 
of fish twice a week (KRAUSS et al., 2000). For individuals 
with a history of CVD, the recommendation is 1 g of EPA and 
DHA per day, and for hypertriglyceridemic individuals, 2 to 
4 g/day ( KRIS-ETHERTON; HARRIS, 2002). The Institute 
of Medicine of the National Academies recommends that 
0.6 to 1.2% of total energy come from ALA, and more than 
10% of this recommendation should be of DHA and EPA. 
The inclusion of 1 to 2 teaspoons per day of the flaxseed oil 
or 1 tablespoon per day of ground flaxseed satisfy the current 
recommendations of ALA. Additionally, 500 mg per day of EPA 
and DHA is recommended to reduce the risk of cardiovascular 
disease, which is equivalent to 2 servings of fish per week, as 
recommended by the AHA (KATCHER et al., 2009).
Saturated fatty acids 
Saturated fatty acids are found predominantly in animal 
products like butter, lard, and beef fat, but can also be obtained 
by the hydrogenation process of vegetable oils. Another 
important source of saturated fatty acids is coconut, cocoa and 
palm oils. It is estimated that the relative ability of the saturated 
fatty acids to promote the increase of serum cholesterol is 
twice greater than lowering the cholesterol promoted by PUFA 
(JAMA, 1972). Therefore, the dietary recommendations aimed 
at reducing the consumption of saturated fatty acids arise out 
of these observations. 
Note that not all saturated fatty acids alter serum lipids in 
the same way. It is recognized that the fatty acids of short chains 
(6:0 to 10:0) and stearic acid (18:0) cause little change in serum 
cholesterol levels (Keys et al., 1965). This is because the fatty 
acids of short chains are absorbed directly into the hepatic portal 
vein, and the stearic acid is rapidly converted to oleic acid (cis-
18: 1n-9) (BONAMONE; GRUND, 1988). Saturated fatty acids 
of intermediate chains, lauric acid (12:0), myristic acid (14:0), 
and palmitic acid (16:0) consumption promotes increasing 
concentrations of plasma cholesterol, probably because they 
influence the reduction in the rate of LDL-C catabolism with 
little or no effect on its production rates (GRUNDY; DENKA, 
1990; MATTHAN et al., 2004). 
The American Heart Association recommends the 
consumption of less than 7% of total dietary energy from 
SFA (LICHTENSTEIN et al., 2006). The replacement of SFA 
by unsaturated fat, carbohydrates, or proteins is an effective 
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of VLDL into LDL (GRUNDY; DENKA, 1990) is added. The 
American Heart Association recommends that cholesterol 
intake stays below 300 mg per day (LICHTENSTEIN et al., 
2006), and the National Cholesterol Education Program ATP 
III recommends the consumption of less than 200 mg per day to 
maximize the reduction of cholesterol by diet (NCEP, 2002). To 
achieve this recommendation, the substitution of meat and other 
animal products for plant foods such as fruits, vegetables, beans, 
peanuts and seeds is recommended since they do not contain 
cholesterol (LICHTENSTEIN et al., 2006). This is a dietary 
strategy indicated for patients at high risk, who are seeking 
significant reduction in total cholesterol and LDL-C. 
Phytosterols 
Phytosterols, sterols, and stanols are structurally similar 
to cholesterol. Stanols are saturated sterols and less abundant 
in nature than sterols (Figure 1). Phytosterols are present in 
small amounts in nuts, seeds, and vegetable oils and perform 
analogous structural functions to cholesterol in animal tissues. 
More than 40 phytosterols have been identified, but sitosterol, 
campesterol, and stigmasterol are the most abundant. The main 
sterol found in foods is the β-sitosterol. While cholesterol is 
absorbed in the gastrointestinal tract in approximately 50%, 
stanols and sterols are absorbed to a lesser extent: 10 to 15% of 
campesterol and campestanol, and 4 to 7% of sitosterol and 1% 
of sitostanol (HEINEMANN et al., 1993).
Studies have shown that phytosterols reduce LDL-C in a 
dose-dependent way. When they are consumed in quantities 
above 2.5 g per day, they present a lowering effect on plasma 
LDL-C in normocholesterolemic and in hypercholesterolemic 
adults (POLI et al., 2008). A meta-analysis of 41 trials reported 
that the intake of 2 g per day of phytosterols reduces by 10% 
LDL-C and a higher intake confers little additional benefit 
(KATAN et al., 2003). The mechanism of action by which 
phytosterols reduce plasma cholesterol is by competing in the 
absorption of cholesterol in the intestine. After the hydrolysis 
of phytosterol esters in the small intestine, free sterols replace 
cholesterol in the micelles and thus reduce the absorption 
of cholesterol, but the exact mechanism is still unknown. It 
is believed that the effects of stanols and sterols involve the 
membrane transport proteins ABCG5 and ABCG8, which 
selectively pump the phytosterols of enterocytes to the intestinal 
lumen (BERGE et al., 2000).
A balanced diet with adequate amounts of vegetables provides 
approximately 200 to 400 mg of phytosterols (SPOSITO et al., 
2007). However, the intake of 2 g/day is necessary, according to 
NCEP (2002), for the average reduction of 10 to 15% of LDL-C 
(GRUNDY, 2005). Phytosterols do not influence plasma levels 
of HDL-C and triglycerides (SPOSITO et al., 2007). 
2.2 Vegetable protein, phytoestrogens and bioactive peptides 
Vegetable protein 
The potential of soy protein to reduce cholesterol has been 
studied extensively in animals and humans. A meta-analysis 
reviewed 38 controlled clinical studies and suggested that the 
The difference between cholesterol and phytosterols is that 
phytosterols have an ethyl group attached to carbon 24. The 
hydrogenation of the double bond 5-6 β-sitosterol converts it 
into sitostanol.
Cholesterol 
Cholesterol is a sterol found in animal products such as eggs, 
organ meats, whole milk and its derivatives, sausages, cold cuts, 
skinless poultry and seafood (shrimp, oysters, shellfish, octopus, 
lobster), and pig meats.
Epidemiological studies and clinical trials have shown that 
dietary cholesterol is positively associated with the risk of CVD 
through an increase in total cholesterol and LDL-C; although 
the main determinant of the increase in LDL-C in humans is the 
consumption of saturated and trans fatty acids (HOWEL et al., 
1997). It is difficult to estimate the absolute effect of dietary 
cholesterol on plasma lipid concentrations because of the high 
degree of individual variability of plasma responses (KATAN; 
BEYENE, 1987). However, a review study of McNamara (2000) 
shows that the additional consumption of 100 mg per day of 
cholesterol increases the total cholesterol by approximately 
2.4 mg.dL–1 and LDL-C by 2.1 mg.dL–1.
Among the mechanisms by which dietary cholesterol 
changes the plasma lipid concentrations, it is featured the 
inhibition of the activity of LDL receptors on the membrane. 
Thus, VLDL-C and LDL-C are not efficiently removed from 
plasma and the effect of the increasing rate of the conversion 
Figure 1. Structure of sterols.
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cholesterol could reduce plasma total cholesterol by 20% and 
non-HDL cholesterol by 22%, in comparison to animals fed 
casein as the protein source (FROTA et al., 2008). 
Another grain that had been recently studied is amaranth, a 
pseudoceral, whose protein isolate (IPA) proved quite effective 
in reducing cholesterol in hypercholesterolemized hamsters. 
The ingestion of 20% amaranth protein or 20% casein + 10% 
amaranth protein resulted in a reduction of total cholesterol of 
48 and 27%, respectively (MENDONÇA et al., 2009).
These results illustrated how plant proteins often show a 
protective effect against hypercholesterolemia. However, this 
effect should not be considered alone. The ideal situation is 
to associate the intake of vegetable protein to the diet, and/or 
feeding a low intake of saturated and trans fat and, to the highest 
possible extent, with limited sources of animal protein, which 
are associated with saturated fat and cholesterol. 
Isoflavones 
Isoflavones are a class of phytoestrogens, a group of 
phytochemical from plant with non-steroidal estrogen-like 
activity. The chemical structure of 17 β-estradiol and equol 
(a metabolite of the phytoestrogen) are very similar (Figure 2). 
The presence of the phenol ring and the distance between 
the hydroxyl group, which are identical in estradiol and 
isoflavones, are considered prerequisites for estrogen action 
(SETCHELL, 1998). It is this chemical and structural similarity 
of endogenous estrogen that leads to the hypothesis that 
isoflavones may be responsible for the hypocholesterolemic 
effect of soy (SETCHELL, 1998). Isoflavones are widespread in 
legumes and are present in greater amounts in soy. Isoflavones 
are associated with the protein, and it is depleted when the 
protein isolation is obtained by alcohol extraction (SETCHELL, 
1998; WANG; MURPHY, 1994). 
Genistein, daidzein and glycitein are the major soy 
isoflavones. Genistein and daidzein are conjugated to sugar as 
glycosides. Isoflavone glycosides cannot be absorbed, unless 
they are hydrolyzed by intestinal microbiota or by in vitro 
fermentation (MINIELLO et al., 2003). 
average intake of 47 g/day of isolated or textured soy protein 
resulted in a significant reduction of 9.3% of total cholesterol, 
12.9% LDL-C and 10.5% triglycerides, with no significant 
changes in HDL-C, in comparison to the group that received 
animal protein (ANDERSON et al., 1995). This change in total 
cholesterol and LDL-C was dependent on the concentration of 
cholesterol at baseline, and it is greater the hypocholesterolemic 
effect in individuals with higher cholesterol levels at baseline. 
A more recent meta-analysis of 10 studies published between 
1995 and 2002, including 959 individuals whose cholesterol 
levels at baseline were between 209 and 255 mg.dL-1 and with 
greater uniformity in experimental designs, showed a weak 
correlation between the change in LDL-C and the consumption 
of soy isoflavones associated (r = –0.33, P = 0.14). An average 
of 52 mg of isoflavones associated with 36 g of soy protein 
daily resulted in a 4% reduction in LDL-C and a 3% increase in 
HDL-C (WEGGEMANS; TRAUTWEIN, 2003). Thus, it seems 
that the hypocholesterolemic effect of soy is relatively modest on 
subjects with mild hypercholesterolemia. A study with women 
in hypercholesterolemic postmenopausal to assess the effect 
of soy protein containing varying amounts of isoflavones (56 
or 90 mg/day) showed that the ingestion of 40 g of soy protein 
with isoflavones was able to reduce the TC: HDL-C at 10% 
for the group receiving soy protein with 56 mg of isoflavones 
(IPS56) and 8% for the group receiving soy protein with 90 mg 
of isoflavones (IPS90), while the casein group increased by 3%. 
With regard to HDL-C, a significant increase of 5.2 and 3.6% for 
IPS56 and IPS90 groups, respectively, and a reduction of 4.1% 
in the group receiving casein (BAUM et al., 1998) was observed. 
Since there was no difference in the lipoprotein concentration 
of the 2 groups that received soy protein, this can be interpreted 
in two ways: either the isoflavone is not involved in the effect on 
humans, or the isoflavone has reached a plateau with respect to 
the ability to influence the blood lipid profile. The mechanism 
of action of soy protein in reducing blood cholesterol has not 
been fully elucidated. The most accepted proposal is that there 
is a change in the hepatic metabolism with an increase in the 
clearance of low density lipoprotein (LDL) and lipoproteins, 
and very low density (VLDL) by hepatocytes, due to increased 
transcription of LDL receptors (LOVATI et al., 2000; CHO et al., 
2008; AZIZ et al., 2008). In addition, some evidence has shown 
that isoflavones found in soy stimulate the activity of proteins 
in reducing blood cholesterol although isoflavones alone do 
not possess this reduction ability (JOINT HEALTH CLAIMS 
INITIATIVE, 2002; FUKUI et al., 2004). 
So far, only soy protein health claim has been approved, 
both nationally and internationally. ANVISA and Joint Health 
Claims Initiative (2002) endorsed the claim that the inclusion 
of at least 25 g of soy protein in the diet can help reduce blood 
cholesterol. The two bodies, respectively, also recommended that 
soy consumption should be associated with a balanced diet and a 
healthy lifestyle, and a diet low in saturated fatty acids. The main 
sources of soy in the diet are soybean oil, soy bean curd (tofu), 
soy sauce, soy flour, soy milk, and soy protein concentrate.
Other legume seed proteins are being studied in order to 
evaluate their hypocholesterolemic effect. The consumption 
of protein isolated from cowpea in hypocholesterolemized 
hamsters with 20% casein + 13% saturated fat + excess Figure 2. Chemical structure of equol and estradiol. 
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A recent study developed with liver cells (Hep G2) treated 
with small peptides from soy 7S subunit showed changes in 
lipid metabolism with a 30% reduction in the accumulation of 
apoB-100 (MOCHIZUKI et al., 2009). 
2.3 Fiber 
The fibers are complex undigested carbohydrates classified 
according to their solubility into soluble and insoluble (SLAVIN, 
1987). Soluble fibers are represented by pectin, guar gum, 
β-glucan and psyllium. Observational studies have shown 
a negative association between the consumption of soluble 
fiber and CVD, and clinical trials show the lowering effect of 
soluble fiber on LDL-C (PEREIRA et al., 2004; THEUWISSEN; 
MENSINK, 2008). The primary mechanism of the soluble fiber 
action for reducing LDL-C is via the absorption of cholesterol 
and bile acids (LIA et al., 1995; MARLETT et al., 1994). 
Soluble fibers are found in fruits (apple, pear, and guava), 
oats, barley, legumes (beans, chickpeas, lentils, and peas), and 
in oat bran food that is rich in soluble fiber (THEUWISSEN; 
MENSINK, 2008). Clinical studies show that the use of 
extract of soluble fiber (β-glucan from barley) in patients with 
moderate dyslipidemia causes a reduction of LDL-C from 
9 to 15% (BEHALL; SCHOLFIELD; HALLFRISCH, 2004; 
KEENAN et al., 2007). 
A meta-analysis evaluated the effectiveness of various 
soluble fibers and the conclusion was that oats, psyllium, pectin, 
and guar gum had a similar effect in reducing the total cholesterol 
and LDL-C (BROWN et al., 1999). This meta-analysis reveals 
that each gram of oat reduced the total cholesterol and LDL-C 
by 1.42 and 1.23 mg.dL–1, respectively, each gram of psyllium 
by 1.10 and 1.11 mg.dL–1, respectively, each gram of pectin by 
2.69 and 1.96 mg.dL–1, respectively, and each gram of guar gum 
by 1.13 and 1.20 mg.dL–1, respectively. 
The recommended intake of total fiber for adults is 20 to 
30 g/day; 5 to 10 g of these should be soluble fiber, as an additional 
measure to reduce cholesterol and therefore, to reduce the 
cardiovascular risk (NCEP, 2001; SPOSITO et al., 2007). 
3 Final remarks
In order to have the desirable blood cholesterol levels and 
lipoprotein profiles, changes in lifestyle are recommended, 
which include primarily the establishment of a healthy diet. 
This diet should limit the intake of foods with high amounts 
of saturated fat, trans fat, and cholesterol, replacing them with 
grains and unsaturated fats from vegetable, fish, legumes, and 
seeds. Food products may be improved by aggregating legume, 
amaranth, quinoa, and other whole grains or their proteins. 
Fiber, especially the soluble one, is another supplement that will 
provide a healthier food product than the original formulation. 
The choice of appropriate foods for a healthy diet is based 
on scientific evidence for each food component. However, 
it is important to emphasize the maintenance of balanced 
dietary patterns, i.e. the suitable combination of macro and 
micronutrients, which cannot be neglected.
In a review of the effects of soy on health, the 4th International 
Symposium on the Role of Soy in Preventing and Treating 
Chronic Diseases, Messina,Gardne and Barnes (2002) 
concluded that the consumption of up to 10g of soy protein 
rich in isoflavones per day may be associated with health 
benefits. In contrast with studies using soy protein, research 
using purified isoflavone supplements has consistently reported 
no effect on plasma lipoprotein LDL-C (NESTEL et al., 1999; 
DEWELL; HOLLENBECK; BRUCE, 2002). It is suggested that 
the potential beneficial effect of soy may be due to the presence 
of the metabolite equol produced by intestinal microbiota from 
daidzein, the main isoflavone in soy (SETCHELL; BROWN; 
LYDEKING-OLSEN, 2002). It has been shown that equol has a 
higher affinity for estrogen receptors than daidzein. It seems that 
about 50 to 70% of the general population can produce equol, 
possibly due to a difference in species of the microbiota of the 
large intestine (SETCHELL; BROWN; LYDEKING-OLSEN, 
2002). However, the publications so far do not support the effect 
of isolated soy isoflavones on the lipid profile (FUKUI et al., 
2004, HALL et al., 2006). Hall et al. (2006) studying the 
effect of isolated isoflavones on lipid biomarkers of risk for 
cardiovascular disease found no significant beneficial effect on 
the concentration of plasma lipids.
Bioactive peptides 
Biologically active peptides or functional peptides are 
peptides derived from food, which also present physiological 
effects to the body (YAMAMOTO et al., 2003). They are 
inactive in the original protein, but once released, they function 
as regulatory components with activity similar to hormones 
(YAMAMOTO et al., 2003). They can be released from the 
original protein during gastrointestinal digestion or during 
food processing. The active peptides generally contain from 
2 to 20 amino acid residues and are partially or totally resistant 
to hydrolysis. They can be absorbed, and thus exert a systemic 
effect.
Since isolated soy protein appears to be the bioactive 
component in soy responsible for the beneficial effect on lipid 
metabolism, a new line of research was developed recently, 
in which the soy peptides are studied. Several studies have 
analyzed the effect of polypeptide subunit of 7S globulin or 
β-conglycinin. Lovati et al. (2000) have identified a polypeptide 
sequence of the 7S globulin protein, present in soybean (subunit 
α’, corresponding to residues 127-150), which are capable of 
increasing the regulation of LDL receptors in Hep G2 cells in “in 
vitro” studies. Moreover, they suggest that this mechanism may 
explain why the effect of soy protein on LDL-C is substantially 
lower in normocholesterolemic individuals and higher in 
individuals with higher level of cholesterol, assuming that the 
down-regulation of LDL receptors is proportional to the degree 
of hypercholesterolemia (LOVATI et al., 2000). 
Duranti et al. (2004) first demonstrated that biologically 
active peptides, derived from the α’ subunit of soybean 
7 S globulin, are able to modulate cholesterol homeostasis by up-
regulation of LDL receptors produced “in vivo”. They detected a 
marked increase in β-VLDL receptor in hypercholesterolemic 
rats treated with the α’ subunit. 
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